Eating DisordersPREGN'EDNCT05885971
Detection of Eating Disorders in Pregnant Women
A study testing Administration of the SCOFF-F and EDE-Q questionnaires in people with Eating Disorders and Pregnancy Related, run by Centre Hospitalier Henri Laborit at 1 site in France.
Trial summary
Eating disorders (ED) are insufficiently detected and belatedly or not treated during pregnancy. There are many screening questionnaires for eating disorders in the literature, but we note the absence of a specific and validated tool for their screening during pregnancy, which would make it possible to differentiate… Read more about this study
- Who is it for?
- Ages 18 years and older, women onlyHealthy volunteers can take part
- Conditions the study is for
- Eating Disorders, Pregnancy Related
- What is being tested?
- Administration of the SCOFF-F and EDE-Q questionnaires
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 50 participants
- Where
- 1 siteFrance
- Study dates
- 30 Jun 2023to Jun 2026
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- Women only
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Adult pregnant woman
- Woman with current diagnosed Eating Disorders or without Eating Disorders
- Having a good command of the French language
- Having given their consent for their participation in the research
Who cannot join
- Underage pregnant woman
- Woman who does not have a good command of the French language.
- Woman with past Eating Disorders
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
France1 site, 1 recruiting
- Recruiting
Centre Hospitalier Henri Laborit
Poitiers
Charlotte XAVIER-DAVID, MD
About this study
Eating disorders (ED) are insufficiently detected and belatedly or not treated during pregnancy.
There are many screening questionnaires for eating disorders in the literature, but we note the absence of a specific and validated tool for their screening during pregnancy, which would make it possible to differentiate maternal dietary concerns related to pregnancy from symptoms linked to a proven eating disorder.
The main objective of the study is to evaluate which items of the Sick Control One stone Fat Food (SCOFF-F) and Eating disorders examination questionnaire (EDE-Q) questionnaires could be specific to an ED during pregnancy and not related to the simple state of pregnancy, by comparing the answers of pregnant women, for whom the diagnosis of ED has been made, to those of pregnant women without an ED.
- Conditions
- Eating Disorders, Pregnancy Related
- Being tested
- Administration of the SCOFF-F and EDE-Q questionnaires
- Medical subject headings
- Feeding and Eating Disorders
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Administration of the SCOFF-F and EDE-Q questionnairesDiagnostic test
The participants will answer to the SCOFF-F and EDE-Q questionnaires as well as socio-demographic questions
| Study group | Role | What they receive |
|---|---|---|
| Group of pregnant women with eating disorder | Other | Not described Receives: Diagnostic Test: Administration of the SCOFF-F and EDE-Q questionnaires |
| Group of pregnant women with no eating disorder | Other | Not described Receives: Diagnostic Test: Administration of the SCOFF-F and EDE-Q questionnaires |
What is being measured
The primary outcome is the main question the study is designed to answer.
Specific Eating Disorders items in pregnant women
A discriminant factor analysis will be used to study whether there are elements that can distinguish women with an Eating Disorders from those who do not have one during pregnancy.
Measured: 36 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted2 Jun 2023
- Study start30 Jun 2023
- Primary completionJun 2026 (estimated)
- Study completionJun 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Eating DisordersStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Diagnosis
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 50 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Centre Hospitalier Henri Laborit
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05885971
- Sponsor's protocol ID
- 2023-A00529-36
- Acronym
- PREGN'ED
- Status last verified
- Jan 2026
- First submitted
- 23 May 2023
- Last updated
- 13 Jan 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 13 Jan 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Detection of Eating Disorders in Pregnant Women
- ClinicalTrials.gov ID
- NCT05885971
- Acronym / sponsor ID
- PREGN'ED / 2023-A00529-36
- Conditions
- Eating Disorders, Pregnancy Related
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 50 participants (estimated)
- Lead sponsor
- Centre Hospitalier Henri LaboritUniversity, hospital or other
- Study start
- 30 Jun 2023 (actual)
- Primary completion
- Jun 2026 (estimated)
- Study completion
- Jun 2026 (estimated)
- First posted
- 2 Jun 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Eating disorders (ED) are insufficiently detected and belatedly or not treated during pregnancy.
There are many screening questionnaires for eating disorders in the literature, but we note the absence of a specific and validated tool for their screening during pregnancy, which would make it possible to differentiate maternal dietary concerns related to pregnancy from symptoms linked to a proven eating disorder.
The main objective of the study is to evaluate which items of the Sick Control One stone Fat Food (SCOFF-F) and Eating disorders examination questionnaire (EDE-Q) questionnaires could be specific to an ED during pregnancy and not related to the simple state of pregnancy, by comparing the answers of pregnant women, for whom the diagnosis of ED has been made, to those of pregnant women without an ED.
Study design
- Primary purpose
- Diagnosis
- Allocation
- Non-randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Group of pregnant women with eating disorder | Other | Diagnostic Test: Administration of the SCOFF-F and EDE-Q questionnaires |
| Group of pregnant women with no eating disorder | Other | Diagnostic Test: Administration of the SCOFF-F and EDE-Q questionnaires |
Who may qualify
- Ages
- 18 years and older
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Adult pregnant woman
- Woman with current diagnosed Eating Disorders or without Eating Disorders
- Having a good command of the French language
- Having given their consent for their participation in the research
Key exclusion criteria (3 listed)
- Underage pregnant woman
- Woman who does not have a good command of the French language.
- Woman with past Eating Disorders
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Administration of the SCOFF-F and EDE-Q questionnairesThe participants will answer to the SCOFF-F and EDE-Q questionnaires as well as socio-demographic questions | Diagnostic test | Group of pregnant women with eating disorder, Group of pregnant women with no eating disorder |
Primary outcome
Specific Eating Disorders items in pregnant women
Time frame: 36 months
A discriminant factor analysis will be used to study whether there are elements that can distinguish women with an Eating Disorders from those who do not have one during pregnancy.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Jan 2026.
Related trials for Eating Disorders
Not yet recruiting
Be Body Brave: Digital Written Exposure Therapy for Eating Disorders
Eating Disorders
Enrolling by invitationPhase 3
A Study to Assess the Long-term Safety and Efficacy of Solriamfetol in Subjects With Binge Eating Disorder
Binge-Eating Disorder
Recruiting
An Online Intuitive Eating Program for Pregnant Women With Obesity to Support Well-Being
Excessive Gestational Weight Gain, Pregnancy
Not yet recruiting
Compulsive Eating and Brain's Reward System in Different Pathologies
PARKINSON DISEASE (Disorder), Bipolar 1 Disorder
Not yet recruitingObservational study
Assessing the Impact of Perceptions of Unpredictability on Objective Measures of Food Consumption and Metabolism
Healthy Volunteer, Obestity
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Administration of the SCOFF-F and EDE-Q questionnaires in people with Eating Disorders and Pregnancy Related, run by Centre Hospitalier Henri Laborit at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 13 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Charlotte XAVIER-DAVID ((0)5 49 52 34 93 ext. +33, charlotte.xavier-david@ch-poitiers.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Specific Eating Disorders items in pregnant women (time frame: 36 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Jan 2026.